363 related articles for article (PubMed ID: 2869996)
1. The Diabetes Control and Complications Trial (DCCT). Design and methodologic considerations for the feasibility phase. The DCCT Research Group.
Diabetes; 1986 May; 35(5):530-45. PubMed ID: 2869996
[TBL] [Abstract][Full Text] [Related]
2. The absence of a glycemic threshold for the development of long-term complications: the perspective of the Diabetes Control and Complications Trial.
Diabetes; 1996 Oct; 45(10):1289-98. PubMed ID: 8826962
[TBL] [Abstract][Full Text] [Related]
3. The relationship of glycemic exposure (HbA1c) to the risk of development and progression of retinopathy in the diabetes control and complications trial.
Diabetes; 1995 Aug; 44(8):968-83. PubMed ID: 7622004
[TBL] [Abstract][Full Text] [Related]
4. Diabetes Control and Complications Trial (DCCT): results of feasibility study. The DCCT Research Group.
Diabetes Care; 1987; 10(1):1-19. PubMed ID: 2882967
[TBL] [Abstract][Full Text] [Related]
5. Diabetes control and complications.
Crofford OB
Annu Rev Med; 1995; 46():267-79. PubMed ID: 7598463
[TBL] [Abstract][Full Text] [Related]
6. Beneficial effects of intensive therapy of diabetes during adolescence: outcomes after the conclusion of the Diabetes Control and Complications Trial (DCCT).
White NH; Cleary PA; Dahms W; Goldstein D; Malone J; Tamborlane WV;
J Pediatr; 2001 Dec; 139(6):804-12. PubMed ID: 11743505
[TBL] [Abstract][Full Text] [Related]
7. Insights from the diabetes control and complications trial/epidemiology of diabetes interventions and complications study on the use of intensive glycemic treatment to reduce the risk of complications of type 1 diabetes.
Genuth S
Endocr Pract; 2006; 12 Suppl 1():34-41. PubMed ID: 16627378
[TBL] [Abstract][Full Text] [Related]
8. Epidemiology of Diabetes Interventions and Complications (EDIC). Design, implementation, and preliminary results of a long-term follow-up of the Diabetes Control and Complications Trial cohort.
Epidemiology of Diabetes Interventions and Complications (EDIC) Research Group
Diabetes Care; 1999 Jan; 22(1):99-111. PubMed ID: 10333910
[TBL] [Abstract][Full Text] [Related]
9. The Diabetes Control and Complications Trial: new challenges for the primary physician.
Clarke WL
Va Med Q; 1994; 121(3):185-8. PubMed ID: 8061070
[No Abstract] [Full Text] [Related]
10. Effect of intensive therapy on the microvascular complications of type 1 diabetes mellitus.
Writing Team for the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Research Group
JAMA; 2002 May; 287(19):2563-9. PubMed ID: 12020338
[TBL] [Abstract][Full Text] [Related]
11. Sustained effect of intensive treatment of type 1 diabetes mellitus on development and progression of diabetic nephropathy: the Epidemiology of Diabetes Interventions and Complications (EDIC) study.
Writing Team for the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Research Group
JAMA; 2003 Oct; 290(16):2159-67. PubMed ID: 14570951
[TBL] [Abstract][Full Text] [Related]
12. Effects of prior intensive versus conventional therapy and history of glycemia on cardiac function in type 1 diabetes in the DCCT/EDIC.
Genuth SM; Backlund JY; Bayless M; Bluemke DA; Cleary PA; Crandall J; Lachin JM; Lima JA; Miao C; Turkbey EB;
Diabetes; 2013 Oct; 62(10):3561-9. PubMed ID: 23520132
[TBL] [Abstract][Full Text] [Related]
13. DCCT: implications for diabetes care in the UK.
Boulton AJ
Diabet Med; 1993 Oct; 10(8):687. PubMed ID: 8261748
[No Abstract] [Full Text] [Related]
14. Clustering of long-term complications in families with diabetes in the diabetes control and complications trial. The Diabetes Control and Complications Trial Research Group.
Diabetes; 1997 Nov; 46(11):1829-39. PubMed ID: 9356033
[TBL] [Abstract][Full Text] [Related]
15. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus.
; Nathan DM; Genuth S; Lachin J; Cleary P; Crofford O; Davis M; Rand L; Siebert C
N Engl J Med; 1993 Sep; 329(14):977-86. PubMed ID: 8366922
[TBL] [Abstract][Full Text] [Related]
16. Modern-day clinical course of type 1 diabetes mellitus after 30 years' duration: the diabetes control and complications trial/epidemiology of diabetes interventions and complications and Pittsburgh epidemiology of diabetes complications experience (1983-2005).
; Nathan DM; Zinman B; Cleary PA; Backlund JY; Genuth S; Miller R; Orchard TJ
Arch Intern Med; 2009 Jul; 169(14):1307-16. PubMed ID: 19636033
[TBL] [Abstract][Full Text] [Related]
17. Effect of intensive therapy on residual beta-cell function in patients with type 1 diabetes in the diabetes control and complications trial. A randomized, controlled trial. The Diabetes Control and Complications Trial Research Group.
Ann Intern Med; 1998 Apr; 128(7):517-23. PubMed ID: 9518395
[TBL] [Abstract][Full Text] [Related]
18. Diabetic retinopathy and other ocular findings in the diabetes control and complications trial/epidemiology of diabetes interventions and complications study.
Aiello LP;
Diabetes Care; 2014; 37(1):17-23. PubMed ID: 24356593
[TBL] [Abstract][Full Text] [Related]
19. Effect of intensive diabetes treatment on the development and progression of long-term complications in adolescents with insulin-dependent diabetes mellitus: Diabetes Control and Complications Trial. Diabetes Control and Complications Trial Research Group.
J Pediatr; 1994 Aug; 125(2):177-88. PubMed ID: 8040759
[TBL] [Abstract][Full Text] [Related]
20. The diabetes control and complications trial/epidemiology of diabetes interventions and complications study at 30 years: overview.
Nathan DM;
Diabetes Care; 2014; 37(1):9-16. PubMed ID: 24356592
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
